TAMPA, Fla.--(BUSINESS WIRE)--Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) today announced that Hopkins Medicine Magazine has published an article in its Winter 2008 edition profiling Revimmune™ as a potential cure for a host of autoimmune diseases.
